The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, Part II:: Treatment of mania

被引:133
作者
Grunze, H
Kasper, S
Goodwin, G
Bowden, C
Baldwin, D
Licht, RW
Vieta, E
Möller, HJ
机构
[1] Univ Munich, Dept Psychiat, D-80336 Munich, Germany
[2] Univ Vienna, Dept Gen Psychiat, Vienna, Austria
[3] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England
[4] Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78285 USA
[5] Univ Southampton, Royal S Hants Hosp, Dept Mental Hlth, Southampton, Hants, England
[6] Aarhus Univ, Hosp Psychiat, DK-8240 Risskov, Denmark
[7] Hosp Clin Barcelona, Dept Psychiat, Barcelona, Spain
关键词
bipolar disorder; mania; acute treatment; evidence-based guidelines; pharmacotherapy; antipsychotics; mood stabiliser; electroconvulsive therapy;
D O I
10.3109/15622970309167904
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Identical to the preceding guidelines of this series, these practice guidelines for the biological, mainly pharmacological treatment of acute bipolar mania were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute mania. The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into four levels of evidence (A-D). As these guidelines are intended for clinical use, the scientific evidence was finally not only graded, but has also been commented by the experts of the task force to ensure practicability.
引用
收藏
页码:5 / 13
页数:9
相关论文
共 84 条
[11]  
BLACK DW, 1987, J CLIN PSYCHIAT, V48, P132
[12]  
Bowden CL, 1998, J CLIN PSYCHIAT, V59, P13
[13]   EFFICACY OF DIVALPROEX VS LITHIUM AND PLACEBO IN THE TREATMENT OF MANIA [J].
BOWDEN, CL ;
BRUGGER, AM ;
SWANN, AC ;
CALABRESE, JR ;
JANICAK, PG ;
PETTY, F ;
DILSAVER, SC ;
DAVIS, JM ;
RUSH, AJ ;
SMALL, JG ;
GARZATREVINO, ES ;
RISCH, SC ;
GOODNICK, PJ ;
MORRIS, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (12) :918-924
[14]  
CALABRESE JR, 1991, J CLIN PSYCHOPHARM, V11, P396
[15]  
CALABRESE JR, 1995, J CLIN PSYCHIAT, V56, P11
[16]  
Calabrese JR, 1996, AM J PSYCHIAT, V153, P759
[17]  
CALABRESE JR, 1993, J CLIN PSYCHOPHARM, V13, P280
[18]   A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder [J].
Calabrese, JR ;
Suppes, T ;
Bowden, CL ;
Sachs, GS ;
Swann, AC ;
McElroy, SL ;
Kusumakar, V ;
Ascher, JA ;
Earl, NL ;
Greene, PL ;
Monaghan, ET .
JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (11) :841-850
[19]   Signs and symptoms of mania in pure and mixed episodes [J].
Cassidy, F ;
Murry, E ;
Forest, K ;
Carroll, BJ .
JOURNAL OF AFFECTIVE DISORDERS, 1998, 50 (2-3) :187-201
[20]   Subtypes of mania determined by grade of membership analysis [J].
Cassidy, F ;
Pieper, CF ;
Carroll, BJ .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (03) :373-383